Ledipasvir Impurity 46 CAS CATO-C4X-331346
| CAS No. | CATO-C4X-331346 |
| Molecular Formula | C15H10BrClO |
| Molecular Weight | 321.60 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Ledipasvir Impurity 46 (CAS CATO-C4X-331346), a pharmacopoeial impurity reference standard (molecular formula C15H10BrClO, MW 321.60 g/mol) used for the identification and quantification of trace impurities in APIs.
Structurally, Ledipasvir Impurity 46 (C15H10BrClO) contains a hydroxyl group, an ether linkage, chlorine/bromine substitution, a polycyclic aromatic system. The molecule exhibits a degree of unsaturation (DBE) of 10.0, corresponding to approximately 10 ring(s) or double-bond equivalent(s). With a molecular weight of 321.60 g/mol, it falls into the moderately-high-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Ledipasvir Impurity 46 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C15H10BrClO |
| Molecular Weight | 321.60 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl/Br-containing |
Related Ledipasvir Standards
- Ledipasvir Impurity 44 (CAS CATO-C4X-331344)
- Ledipasvir Impurity 56 (CAS CATO-C4X-331356)
- Ledipasvir Impurity 19 (CAS CATO-C4X-331319)
- Ledipasvir Impurity 41 (CAS CATO-C4X-331341)
- Ledipasvir Impurity 52 (CAS CATO-C4X-331352)
- Ledipasvir Impurity 50 (CAS CATO-C4X-331350)
- Ledipasvir Impurity 21 (CAS CATO-C4X-331321)
- Ledipasvir Impurity 40 (CAS CATO-C4X-331340)
Recommended Standards
- Tert-butyl ((5-bromo-6-chloropyridin-3-yl)methyl)carbamate (CAS 2231673-63-3)
- 2-Chloro-N-[4-(2,5-dichlorophenyl)-1,3-thiazol-2-yl]acetamide (CAS 1365963-22-9)
- tert-Butyl ((5-bromo-6-chloropyridin-2-yl)methyl)carbamate (CAS 871728-54-0)
- 8-Chloro-1-methyl-2-oxo-1,2,3,4-tetrahydroquinoline-6-boronic Acid Pinacol Ester (CAS 1427588-44-0)
- Ixazomib Impurity 46 (CAS CATO-C4X-126746)
- Sitafloxacin impurity 89 (CAS CATO-C4X-115589)
- Zidovudine Impurity 04 (CAS 73971-82-1)
- 4-Chloro-6-(difluoromethyl)-3-fluoropicolinaldehyde (CAS 1805999-43-2)
- methyl 2-(4-aminophenoxy)benzoate (CAS 212189-58-7)
- Ethyl 1-(3,5-dichlorophenyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazole-3-carboxylate (CAS 1000576-61-3)
- 1-[(2H-1,3-Benzodioxol-5-yl)methyl]-4-[1-(6-methylpyridin-2-yl)-1H-imidazole-4-carbonyl]piperazine (CAS 477890-24-7)
- (2S,5R)-ethyl 5-((benzyloxy)amino)-1-(2,2,2-trifluoroacetyl)piperidine-2-carboxylate (CAS 2380736-50-3)
- 1-Ethyl-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazolo[5,4-b]pyridin-2-yl)urea (CAS 1160791-16-1)
- D-Gln24-Tirzepatide (CAS CATO-CPTD788910)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com